Skip to main content
OpenTrials

Clinical trial condition

Amyloidosis

Explore clinical trials studying Amyloidosis. Study availability and eligibility vary by location and protocol.

187 public trials 49 recruiting studies
Refine in advanced search Browse all conditions

Amyloidosis trial results

Completed

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

NCT00035334

Conditions
Amyloidosis, Arthritis, Arthritis, Rheumatoid, +32 more
Locations
  • Indiana University School of Medicine, Department of Pathology and Laboratory Medicine, Indianapolis, Indiana, United States
  • Boston Medical Center, Renal Division Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Mount Sinai Medical Center New York, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis

NCT06097832

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • Sutter Health Alta Bates Berkeley, California, United States
  • City of Hope Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis

NCT05250973

Conditions
Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations
  • City of Hope Duarte, California, United States
  • Yale New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute Emory University Atlanta, Georgia, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

Study of ALXN2220 Versus Placebo in Adults With ATTR-CM

NCT06183931

Conditions
Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +2 more
Locations
  • Research Site Irvine, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site San Francisco, California, United States
View all 212 locations
View Trial Details
Active, Not Recruiting

HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

NCT04153149

Conditions
Amyloidosis, Amyloidosis, Familial, Amyloidosis, Hereditary, Transthyretin-Related, +10 more
Locations
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Los Angeles, California, United States
  • Clinical Trial Site Stanford, California, United States
  • Clinical Trial Site Washington D.C., District of Columbia, United States
View all 119 locations
View Trial Details
Active, Not Recruiting

Study of Re-Treatment With ALXN2220 in Patients With ATTR-CM

NCT07213583

Conditions
Amyloid Transthyretin Cardiomyopathy, Amyloidosis, Metabolic Diseases, +2 more
Locations
  • Hôpital Henri Mondor Créteil, France
  • CHU de Rennes - Hôpital Pontchaillou Rennes, France
  • CHU Toulouse - Hôpital Rangueil Toulouse, France
  • Universitätsklinikum Heidelberg Heidelberg, Germany
View Trial Details

Related conditions